Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

Video Credit: ANI
Published on April 23, 2021 - Duration: 02:01s

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults.

A release by Cadila Health said, "The drug has also shown efficacy against other viral infections."Speaking on the development, Dr Sharvil Patel, Managing Director, Cadila Healthcare Limited said: "The fact that we are able to offer a therapy which significantly reduces viral load when given early on can help in better disease management.

It comes at a much-needed time for patients and we will continue to provide them access to critical therapies in this battle against COVID-19." This government's approval for use of the antiviral drug comes at a time when India's daily COVID tally is crossing the 3-lakh mark.

India recorded 3,32,730 new COVID-19 cases in the last 24 hours, the highest single-day spike since the pandemic broke out last year.

India has crossed the mark of 3 lakh COVID-19 cases for two consecutive days now.

This has taken the cumulative count of the COVID infection in the country to 1,62,63,695.

You are here

💡 newsR Knowledge: Other News Mentions


Disease caused by severe acute respiratory syndrome coronavirus 2
Newly-appointed Karnataka Chief Minister Basavaraj Bommai on Saturday said the Centre has agreed to increase the monthly supply of Covid-19 vaccines to the..
Credit: IndiaTimes - Published 39 minutes ago

The Centre has released 15 per cent of the amount under the Covid-19 Emergency Response and Health System Preparedness (ECRP-II) Package to the states to improve..
Credit: IndiaTimes - Published 1 hour ago

On Saturday, the team has reached Alpuzha and is on the grounds. Kerela is observing a complete lockdown on the weekends.
Credit: DNA - Published 1 hour ago

The emergence of a new COVID variant with a similar death rate to MERS, which kills one in three infected people, is a "realistic possibility", the government's..
1 hour ago • Sky News
The NFL Alumni association was paid a whopping $3,500,000 by the CDC to promote the COVID-19 vaccine, TMZ Sports has learned. U.S. Federal Procurement docs show..
Credit: TMZ.com - Published 3 hours ago

Related videos from verified sources

What is Virafin? How does the Zydus Cadila drug work? | Oneindia News 01:24
Video credit: Oneindia - Published on April 24, 2021 

Covid-19: Centre to fast-track emergency approval for vaccines| Oneindia News 02:13
Video credit: Oneindia - Published on April 13, 2021 

Vaccinations for 12 to 15-year-olds could be available in weeks 03:08
Video credit: KMTV Action 3 News - Published on April 12, 2021 

You might like